The heme oxygenase-1 metalloporphyrin inhibitor stannsoporfin enhances the bactericidal activity of a novel regimen for multidrug-resistant tuberculosis in a murine model.
Heme-oxygenase 1
Host-directed therapies
Mycobacterium tuberculosis
chemotherapy
drug resistance
Journal
bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187
Informations de publication
Date de publication:
13 Nov 2023
13 Nov 2023
Historique:
pubmed:
23
8
2023
medline:
23
8
2023
entrez:
23
8
2023
Statut:
epublish
Résumé
Multidrug-resistant (MDR)
Identifiants
pubmed: 37609351
doi: 10.1101/2023.08.09.552716
pmc: PMC10441415
pii:
doi:
Types de publication
Preprint
Langues
eng
Subventions
Organisme : NIAID NIH HHS
ID : K24 AI143447
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA006973
Pays : United States
Références
J Immunol. 2010 Nov 1;185(9):5279-88
pubmed: 20921523
Antimicrob Agents Chemother. 1992 Mar;36(3):548-51
pubmed: 1622164
Immunology. 2018 Jun;154(2):186-195
pubmed: 29455468
Respirology. 2018 Jul;23(7):656-673
pubmed: 29641838
Antimicrob Agents Chemother. 2023 Apr 18;67(4):e0003523
pubmed: 36920217
Clin Exp Immunol. 2015 Feb;179(2):265-76
pubmed: 25196646
J Infect Dis. 2019 Apr 19;219(10):1518-1524
pubmed: 30590592
Front Oncol. 2022 Feb 17;12:775649
pubmed: 35251964
Am J Respir Cell Mol Biol. 2011 Jul;45(1):172-80
pubmed: 20889800
BMC Public Health. 2010 May 19;10:259
pubmed: 20482835
J Antimicrob Chemother. 2010 Apr;65(4):729-34
pubmed: 20123722
Infect Immun. 1990 Aug;58(8):2675-7
pubmed: 2115027
Commun Biol. 2022 May 19;5(1):480
pubmed: 35590096
Annu Rev Immunol. 2009;27:393-422
pubmed: 19302046
Front Immunol. 2022 May 06;13:747799
pubmed: 35603185
Expert Rev Mol Med. 2011 Dec 16;13:e39
pubmed: 22172201
mBio. 2016 Oct 25;7(5):
pubmed: 27795400
Nat Med. 2000 Apr;6(4):422-8
pubmed: 10742149
PLoS One. 2015 Dec 23;10(12):e0145342
pubmed: 26699615
Front Immunol. 2017 May 12;8:542
pubmed: 28553288
Proc Natl Acad Sci U S A. 1968 Oct;61(2):748-55
pubmed: 4386763
Annu Rev Pharmacol Toxicol. 1997;37:517-54
pubmed: 9131263
Am J Pathol. 2006 Jul;169(1):21-31
pubmed: 16816358
Infect Immun. 1999 Aug;67(8):3980-8
pubmed: 10417164
Cancer Res. 2013 Dec 1;73(23):7009-21
pubmed: 24121491
Immunol Rev. 2018 Sep;285(1):147-167
pubmed: 30129209
Eur Respir Rev. 2019 May 29;28(152):
pubmed: 31142549
Immunol Rev. 2021 May;301(1):62-83
pubmed: 33565103
Mucosal Immunol. 2021 Jan;14(1):253-266
pubmed: 32862202
Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10919-24
pubmed: 9380735
Trends Mol Med. 2009 Feb;15(2):50-8
pubmed: 19162549
Arch Biochem Biophys. 2014 Dec 15;564:83-8
pubmed: 25241054
Am J Respir Cell Mol Biol. 2009 Sep;41(3):251-60
pubmed: 19617398
Annu Rev Immunol. 2001;19:93-129
pubmed: 11244032
Pediatrics. 2004 Jul;114(1):297-316
pubmed: 15231951
Cytometry A. 2014 Feb;85(2):151-61
pubmed: 24339210
Cold Spring Harb Perspect Med. 2015 Apr 27;5(9):a017863
pubmed: 25918181
Nat Immunol. 2005 May;6(5):472-80
pubmed: 15834410
Free Radic Biol Med. 2000 Jan 15;28(2):289-309
pubmed: 11281297
J Immunol. 2016 Jun 1;196(11):4641-9
pubmed: 27183573
Am J Pathol. 2004 Sep;165(3):1045-53
pubmed: 15331427
Int J Tuberc Lung Dis. 2020 Aug 1;24(8):820-828
pubmed: 32912387